Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, August 17, 2023
[ Thu, Aug 17th 2023
] - WOPRAI
[ Thu, Aug 17th 2023
] - WOPRAI
[ Thu, Aug 17th 2023
] - WOPRAI
[ Thu, Aug 17th 2023
] - WOPRAI
[ Thu, Aug 17th 2023
] - WOPRAI
[ Thu, Aug 17th 2023
] - WOPRAI
[ Thu, Aug 17th 2023
] - WOPRAI
[ Thu, Aug 17th 2023
] - WOPRAI
[ Thu, Aug 17th 2023
] - WOPRAI
[ Thu, Aug 17th 2023
] - WOPRAI
[ Thu, Aug 17th 2023
] - WOPRAI
[ Thu, Aug 17th 2023
] - WOPRAI
[ Thu, Aug 17th 2023
] - WOPRAI
[ Thu, Aug 17th 2023
] - WOPRAI
[ Thu, Aug 17th 2023
] - WOPRAI
[ Thu, Aug 17th 2023
] - WOPRAI
[ Thu, Aug 17th 2023
] - WOPRAI
[ Thu, Aug 17th 2023
] - WOPRAI
[ Thu, Aug 17th 2023
] - WOPRAI
[ Thu, Aug 17th 2023
] - WOPRAI
[ Thu, Aug 17th 2023
] - WOPRAI
[ Thu, Aug 17th 2023
] - WOPRAI
[ Thu, Aug 17th 2023
] - WOPRAI
[ Thu, Aug 17th 2023
] - WOPRAI
[ Thu, Aug 17th 2023
] - WOPRAI
[ Thu, Aug 17th 2023
] - WOPRAI
[ Thu, Aug 17th 2023
] - WOPRAI
[ Thu, Aug 17th 2023
] - WOPRAI
Asthika Goonewardene Maintained (AUTL) at Strong Buy with Increased Target to $9 on, Aug 17th, 2023
Asthika Goonewardene of Truist Securities, Maintained "Autolus Therapeutics plc" (AUTL) at Strong Buy with Increased Target from $6 to $9 on, Aug 17th, 2023.
Asthika has made no other calls on AUTL in the last 4 months.
There are 2 other peers that have a rating on AUTL. Out of the 2 peers that are also analyzing AUTL, 0 agree with Asthika's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Asthika
- Gil Blum of "Needham" Reiterated at Strong Buy and Held Target at $7 on, Monday, June 5th, 2023
- Vanck Zhu of "Wells Fargo" Maintained at Buy with Decreased Target to $6 on, Friday, May 5th, 2023
